Cannabics Pharmaceuticals Inc.
Cannabics Pharmaceuticals Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. The company focuses on developing and marketing bioinformatic delivery systems for cannabinoids, personalized medicine therapies, and procedures based on cannabis originated compounds and bioinformatics tools. Its lead product candidate is RCC-33, an oral capsule containing a formulation of cannabinoids for the treatment of colorectal cancer. The company is also developing Cannabics SR, a lipid-based capsule containing a standardized formulation of cannabinoids for the treatment of cancer anorexia-cachexia syndrome; and Cannabics CDx, a drug sensitivity test for cannabinoid-based cancer therapies. The company was formerly known as American Mining Corporation and changed its name to Cannabics Pharmaceuticals Inc. in May 2014. Cannabics Pharmaceuticals Inc. was founded in 2004 and is based in Bethesda, Maryland. Cannabics Pharmaceuticals Inc. is a subsidiary of Cannabics Inc. Show More...
-
Website http://cannabics.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 0.00 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2011-08 2012-08 2013-08 2014-08 2015-08 2016-08 2017-08 2018-08 2019-08 2020-08 TTM Earnings Per Share USD -0.08 -0.04 -0.010 -0.010 -0.03 0.02 -0.1 -0.07 Dividends USD Payout Ratio % * Shares Mil 1.0 1.0 1.0 100.0 101.0 103.0 110.0 120.0 132.0 135.0 135.0 Book Value Per Share * USD -0.03 -0.03 -0.05 0.04 0.02 0.02 0.14 0.04 0.010 Free Cash Flow Per Share * USD -0.010 -0.02 -0.03 -0.02 Return on Assets % -226.01 -155.04 -11.75 -23.78 -105.63 -110.71 12.34 -85.82 -73.04 Financial Leverage (Average) 1.02 1.24 1.2 1.03 1.26 1.35 Return on Equity % -12.43 -26.15 -156.51 -135.26 13.03 -90.47 -81.9 Return on Invested Capital % -12.38 -26.01 -156.16 -135.26 13.18 -90.37 -81.9 Interest Coverage -314.09 -224.69 -177.91 -10.3 -441.22 62.75 -917.17 Current Ratio 0.41 1.52 0.08 0.04 5.03 3.0 9.81 2.04 0.8 Quick Ratio 0.41 1.33 0.07 0.04 5.03 3.0 8.67 2.04 0.8 Debt/Equity